Ozempic and Mounjaro May Have Unexpected Effects on the Brain

Written by

in

Researchers from the University of Gothenburg and the University of Copenhagen were invited by Science to review existing evidence on how GLP-1 drugs such as Ozempic and Mounjaro affect brain function. Animal studies suggest potential benefits for learning and memory, but findings in humans are mixed. In Novo Nordisk’s EVOKE and EVOKE+ trials, semaglutide did not slow the progression of early Alzheimer’s disease. Medical-record analyses have found only an association between lower dementia risk and type 2 diabetes. Whether early treatment can protect cognitive function remains to be confirmed through clinical trials.

Source:ScienceDaily · Read original article

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *